Finance

Beta
Lists
CBAV:BME
Clinica Baviera SA
€57.40
0.00%
(0.00) 1D
Jun 3, 12:31:03 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CBAV...
Open
€57.20
High
€57.40
Low
€57.20
Mkt. cap
936.06M
Avg. vol.
2.87K
Volume
240.00
Dividend
2.74%
Quarterly dividend
€0.39
Ex-dividend date
Jun 10, 2026
P/E ratio
21.85
52-wk high
€59.80
52-wk low
€38.10
EPS
€2.63
Shares outstanding
16.31M
No. of employees
2K
Open
€57.20
High
€57.40
Low
€57.20
Mkt. cap
936.06M
Avg. vol.
2.87K
Volume
240.00
Dividend
2.74%
Quarterly dividend
€0.39
Ex-dividend date
Jun 10, 2026
P/E ratio
21.85
52-wk high
€59.80
52-wk low
€38.10
EPS
€2.63
Shares outstanding
16.31M
No. of employees
2K
News stories
From sources across the web
About Clinica Baviera SA
CEO-
Employees1.59K
FoundedFeb 5, 1992
Headquarters-
SectorHealth care provider
Websiteclinicabaviera.com
Last report
Feb 27, 2026
Fiscal period
Q4 2025
EPS / Est. (EUR)
€0.60 / -
0.00%miss
Revenue / Est. (EUR)
301.78M / -
0.00%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
80.22M
74.52M
65.30M
84.87M
Cost of goods sold
56.08M
54.17M
50.37M
-6.69M
Cost of revenue
56.08M
54.17M
50.37M
-6.69M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
17.78M
Operating expense
5.74M
5.66M
6.23M
72.70M
Total operating expenses
61.82M
59.83M
56.60M
66.01M
Operating income
18.40M
14.69M
8.70M
18.86M
Other non operating income
-
-1.00K
2.00K
-1.00K
EBT including unusual items
18.06M
14.36M
8.18M
19.51M
EBT excluding unusual items
18.06M
14.36M
8.18M
19.24M
Income tax expense
5.19M
4.42M
2.70M
4.88M
Effective tax rate
28.72%
30.77%
32.94%
24.99%
Other operating expenses
-
-
-
48.67M
Net income
12.87M
9.94M
5.49M
13.77M
Net profit margin
16.05%
13.34%
8.40%
16.22%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
1.52M
Interest expense
-338.00K
-329.00K
-521.00K
-1.09M
Net interest expenses
-338.00K
-329.00K
-521.00K
427.87K
Depreciation and amortization charges
-
-
-
-
EBITDA
24.14M
20.35M
14.93M
23.35M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer